A Method Of Characterising An Immunosuppressive Neutrophil

    公开(公告)号:US20240110241A1

    公开(公告)日:2024-04-04

    申请号:US18256303

    申请日:2021-12-07

    CPC classification number: C12Q1/6881 C12Q2600/158 G01N2800/52 G01N2800/56

    Abstract: The invention relates to a method of detecting and/or characterising an immunosuppressive neutrophil comprising determining and/or measuring the expression of one or more anti-apoptotic markers in a neutrophil population. In an embodiment, the immunosuppressive neutrophil is a polymorphonuclear myeloid-derived suppressor cell (PMNMDSC) and the anti-apoptotic marker is TNF-related apoptosis-inducing ligand (TRAIL)-receptor 3 (TRAILR3/TNFRSF10C) and/or decoy TNF-related apoptosis-inducing ligand (TRAIL)-receptor (dcTRAILR1). Also disclosed are methods of evaluating the progression of a proliferative disease in a subject, methods of evaluating the efficacy of a treatment regimen for a proliferative disease in a subject, methods of treating a proliferative disease in a subject, and kits thereof.

    Neutrophil Progenitors and Related Methods and Uses

    公开(公告)号:US20230213513A1

    公开(公告)日:2023-07-06

    申请号:US18000559

    申请日:2021-06-11

    CPC classification number: G01N33/56972 G01N2333/705

    Abstract: There is provided a method of identifying a neutrophil progenitor, the method comprising: determining an expression of at least one biomarker selected from the group consisting of: CD71, LOX-1, CD164, CD112, CD181, TACSTD2, CD11b and CD49d in a cell. In various embodiments, the cell is identified as a neutrophil progenitor when it is determined to have at least one of the following expression profiles: CD71hi/+, LOX-1int/lo/−, CD164hi/+, CD112hi/+, CD181int/lo/−, TACSTD2hi/+, CD11blo/− and/or CD49dint/hi/+. Also disclosed are a method of sorting and/or separating neutrophil progenitors from a cell population, a composition that is enriched in neutrophil progenitors and related uses and methods.

Patent Agency Ranking